Quantcast

Latest research Stories

2014-08-20 16:25:31

SOUTH PLAINFIELD, N.J., Aug. 20, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it will participate at two upcoming investor conferences: http://photos.prnewswire.com/prnvar/20010919/PTCLOGO - FBR 1(st) Annual Healthcare Conference at the Four Seasons Hotel in Boston on Wednesday, September 3(rd) - Citi's 9(th) Annual Biotech Conference at The Mandarin Oriental Boston on Thursday, September 4(th) In addition, management will present a company...

2014-08-20 08:27:41

ENGLEWOOD, Colo., Aug. 20, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that in response to requests from patients and physicians, the company has performed an analysis of the available data from both portions of the study. On October 7, 2013, following an IDRC determination "that there was a treatment dosage (of Optina(TM)) that was demonstrating a potentially beneficial anatomic effect." The company initiated an open label extension study using the...

2014-08-20 08:25:06

New funding to bolster product development and expand Kasisto's footprint in the financial services market NEW YORK, Aug. 20, 2014 /PRNewswire/ -- Kasisto, provider of a conversational artificial intelligence platform for enterprise mobile applications, today announced it has secured $2.25 million in seed funding. The round was led by New York Angels with participation from Two Sigma Ventures, the Partnership Fund for New York City, the Wells Fargo Startup Accelerator, Harvard...

2014-08-19 23:13:32

With more than 50 years of combined experience, expert presenters Sherri Hubby and Brian Nugent will share insights that can be used to establish Risk Based Monitoring Plans, including triggers for return to 100% source data verification. Even better, they'll show attendees how to proactively identify and manage risks to trials with methods that can immediately be implemented and used. Falls Church, VA (PRWEB) August 19, 2014 Managing Risk for Clinical Trials: Incorporating Quality by...

2014-08-19 08:30:32

GLEN BURNIE, Md., Aug. 19, 2014 /PRNewswire/ -- CSSi, the leader in patient recruitment solutions for the clinical research industry, recently announced the formation of the company's Medical and Clinical Advisory Board ("MCAB") and is pleased to announce the addition of Dr. William E. Gannon, Jr. to the MCAB. Photo - http://photos.prnewswire.com/prnh/20140818/136957 The MCAB, with Dr. Gannon's leadership, will help provide insight across a variety of therapeutic areas and set...

2014-08-18 12:27:56

ELLICOTT CITY, Md., Aug. 18, 2014 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS), the trade organization representing over 1,500 clinical research sites in 37 countries, today announced INC Research, a leading, global Phase I to IV clinical research organization (CRO), will sponsor site appreciation events at the society's annual Site Solutions Summit, Oct. 10-12, 2014, on Amelia Island, Fla. and its inaugural European Summit, March 25-27, 2015, in Croatia. "We are...

2014-08-18 08:28:40

SHANGHAI, Aug. 18, 2014 /PRNewswire/ -- WuXiPharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that a manufacturing facility of WuXi's wholly owned subsidiary Shanghai SynTheAll Pharmaceutical Co. Ltd. (STA) passed an FDA inspection in July for the manufacture of the active pharmaceutical ingredient (API) for a branded commercial drug. This...

2014-08-14 16:27:04

SANTA ROSA, Calif., Aug. 14, 2014 /PRNewswire/ -- Ruthigen, Inc. (NASDAQ: RTGN) today reported financial results for its fiscal first quarter 2015 ended June 30, 2014. Company Highlights -- Ruthigen Initiated Human Clinical Trials for RUT 58-60 in the U.S. In July 2014, Ruthigen began human clinical testing of RUT58-60 in its 21-day skin irritation trial. -- Ruthigen Completed the Skin Irritation Trial. In August 2014, Ruthigen completed the skin irritation...

2014-08-13 23:03:42

Researchmoz.us announces addition of new report "Neuropathy Global Clinical Trials Review, H2, 2014" to its database. Albany, NY (PRWEB) August 13, 2014 "Clinical trial report, Neuropathy Global Clinical Trials Review, H2, 2014" provides data on the Neuropathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neuropathy. It includes an overview of the trial numbers and their recruitment status as per the...

2014-08-13 12:25:29

LONDON, Aug. 13, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Analytical Instrument Market in the US 2014-2018https://www.reportbuyer.com/product/2133092/Analytical-Instrument-Market-in-the-US-2014-2018.htmlAbout Analytical InstrumentsAnalytical instruments are types of precision engineering equipment used to continuously monitor numerous parameters during the manufacturing process. These instruments are also often known as online instruments. They are...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.